| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +365 K | 55.4% | $4.92 | +$1.8 M |
| Sells | 5 | -293 K | 44.6% | $17.03 | -$5 M |
| Net | -3 | +71.6 K | 10.9% | -$3.2 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Biotech Target N V | 10%+ Owner | $119 M | +$1.72 M | +1.47% | Oct 2, 2023 |
| Scott Koenig | President and CEO, Director | $20.6 M | Feb 15, 2024 | ||
| Eric Blasius Risser | Chief Operating Officer | $4.18 M | -$814 K | -16.3% | Mar 4, 2024 |
| James Karrels | SVP, CFO and Secretary | $4.16 M | -$615 K | -12.9% | Mar 4, 2024 |
| Thomas Spitznagel | Sr VP, Technical Ops | $2.04 M | -$200 K | -8.93% | Mar 4, 2024 |
| Ezio Bonvini | Sr VP, Research & CSO | $1.86 M | -$610 K | -24.7% | Feb 22, 2024 |
| Jeffrey Stuart Peters | Senior VP and General Counsel | $1.29 M | -$2.76 M | -68.1% | Apr 4, 2024 |
| Lynn Cilinski | VP, Controller and Treasurer | $1.16 M | Feb 15, 2024 | ||
| Edward Hurwitz | Director | $971 K | +$73.7 K | +8.21% | May 21, 2024 |
| Stephen L. Eck | Chief Medical Officer | $886 K | Feb 15, 2024 | ||
| William K. Heiden | Director | $368 K | May 21, 2024 | ||
| David C. Stump | Director | $368 K | May 21, 2024 | ||
| Karen Jean Ferrante | Director | $368 K | May 21, 2024 | ||
| Scott Thomas Jackson | Director | $368 K | May 21, 2024 | ||
| Federica F. O'Brien | Director | $368 K | May 21, 2024 | ||
| Meenu Chhabra | Director | $323 K | May 21, 2024 | ||
| Jay Philip Siegel | Director | $261 K | May 21, 2024 | ||
| Margaret Liu | Director | $261 K | May 21, 2024 | ||
| Paulo F. Costa | Director | $22.7 K | May 13, 2021 | ||
| Kenneth Galbraith | Director | $22.7 K | May 13, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|